Boai NKY Medical Holdings Ltd operates in the Industrial organic chemicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Boai NKY Medical Holdings Ltd with three other
companies in this sector in CHINA :
Henan Jindan Lactic Acid Technology Co Ltd
sales of 877.24 million Chinese Renmimbi [US$133.34 million]
of which 65%
was Lactic Acid),
Shandong Head Co Ltd
(1.11 billion Chinese Renmimbi [US$169.15 million]
of which 69%
was Cellulose ether products), and
Liaoning Kelong Fine Chemical Inc
(944.67 million Chinese Renmimbi [US$143.59 million]
of which 80%
was Concrete Admixture Business).
Boai NKY Medical Holdings Ltd reported sales of 924.43 million Chinese Renmimbi (US$140.51 million)
December of 2019.
increase of 32.4%
versus 2018, when the company's sales were 698.28 million Chinese Renmimbi.
Sales at Boai NKY Medical Holdings Ltd have increased during each of the previous five years
(and since 2014, sales have increased a total of 265%).
Sales of China saw an increase
that was more than double the company's growth rate: sales were up
65.2% in 2019, from
509.50 million Chinese Renmimbi to 841.63 million Chinese Renmimbi.
Not all segments of Boai NKY Medical Holdings Ltd experienced an increase in sales in 2019:
sales of Other Foreign fell 37.5% to 145.84 million Chinese Renmimbi.